Abstract:Due to ineffective diagnosis and analysis, glioblastoma multiforme (GBM), is still the most aggressive form of all cancers. Standard therapy for GBM comprises resection surgery following chemo and radiotherapy, which offers less efficacious treatment to the malignant nature of glioma. Several treatment strategies involving gene therapy, immunotherapy, and angiogenesis inhibition have been employed recently as alternative therapeutics. The main drawback of chemotherapy is resistance, which is mainly due to the enzymes involved in the therapeutic pathways. Our objective is to provide a clear insight into various nano-architectures used in the sensitization of GBM and their importance in drug delivery and bioavailability. This review includes the overview and summary of articles from Pubmed and Scopus search engines. The present era's synthetic and natural drugs used in the treatment of GBM are facing poor Blood Brain Barrier (BBB) permeability issues due to greater particle size. This problem can be resolved by using the nanostructures that showcase high specificity to cross the BBB with their nano-scale size and broader surface area. Nano-architectures act as promising tools for effective brain-targeted drug delivery at a concentration well below the final dose of free drug, thus resulting in safe therapeutic effects and reversal of chemoresistance. The present review focuses on the mechanisms involved in the resistance of glioma cells to chemotherapeutic agents, nano-pharmacokinetics, diverse types of nano-architectures used for potent delivery of the medicine and sensitization in GBM, their recent clinical advances, potential challenges, and future perspective.

Strategies to Improve Drug Delivery Across the Blood–Brain Barrier for Glioblastoma

Overcoming Barriers in Glioblastoma—Advances in Drug Delivery Strategies

Improving glioma drug delivery: A multifaceted approach for glioma drug development

Pharmacological strategies for improving the prognosis of glioblastoma

Recent developments in drug delivery strategies for targeting DNA damage response in glioblastoma

Innovative drug delivery strategies for targeting glioblastoma: overcoming the challenges of the tumor microenvironment

Regulation of pathological blood-brain barrier for intracranial enhanced drug delivery and anti-glioblastoma therapeutics

Blood-Brain Barrier Conquest in Glioblastoma Nanomedicine: Strategies, Clinical Advances, and Emerging Challenges

The Blood-Brain/tumor Barriers: Challenges and Chances for Malignant Gliomas Targeted Drug Delivery.

Challenges and advances in glioblastoma targeted therapy: the promise of drug repurposing and biomarker exploration

Targeted Regulation of Blood-Brain Barrier for Enhanced Therapeutic Efficiency of Hypoxia-Modifier Nanoparticles and Immune Checkpoint Blockade Antibodies for Glioblastoma

Contemporary strategies in glioblastoma therapy: Recent developments and innovations

Targeting the undruggable in glioblastoma using nano-based intracellular drug delivery

Biomimetic nanoparticle-driven strategies for targeted drug delivery in glioblastoma

Drug delivery to tumors of the central nervous system

Comprehensive insights into glioblastoma multiforme: drug delivery challenges and multimodal treatment strategies

Brain-targeted Nano-architectures for Efficient Drug Delivery and Sensitization in Glioblastoma

Revolutionizing Brain Tumor Care: Emerging Technologies and Strategies

Polymer nanocarriers for targeted local delivery of agents in treating brain tumors

Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier

Current strategic arsenal and advances in nose to brain nanotheranostics for therapeutic intervention of glioblastoma multiforme